TOT BIOPHARM INTL CO LTD financial statements, including revenue, expenses, profit, and loss
The total revenue of 1875 for the last semiannual is 488.92 M HKD, and it's 31.78% higher compared to the previous semiannual. The net income of H2 23 is -24.41 M HKD.